Screener
Arcus Biosciences RCUS Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebt.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's long-term debt?
- Arcus Biosciences (RCUS) reported long-term debt of $101M in Q2 2026.
- How has Arcus Biosciences's long-term debt changed year-over-year?
- Arcus Biosciences's long-term debt increased by 4.1% year-over-year, from $97M to $101M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Arcus Biosciences's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude